Thrombocytopenia và Thrombosis: Một Lưỡi Dao Hai Duyên

Clinical Rheumatology - Tập 33 - Trang 587-590 - 2013
Myat Tun Lin Nyo1, Asgar Ali Kalla2
1Department of Medicine, Division of Rheumatology, Medical University of Southern Africa, Pretoria, South Africa
2Department of Medicine, Division of Rheumatology, University of Cape Town, Cape Town, South Africa

Tóm tắt

Thiếu tiểu cầu nặng kèm theo chảy máu liên quan đến một biểu hiện huyết khối đe dọa tính mạng trong bối cảnh hội chứng kháng phospholipid là một thách thức lớn về chẩn đoán và điều trị đối với lâm sàng. Chảy máu là một biến chứng ít phổ biến hơn so với huyết khối ở những bệnh nhân bị APS, mặc dù thiếu tiểu cầu nặng đôi khi có thể dẫn đến chảy máu. Hiện không có hướng dẫn dựa trên bằng chứng nào về cách quản lý bệnh nhân có thiếu tiểu cầu nặng liên quan đến một biểu hiện huyết khối lớn. Trong báo cáo trường hợp này, chúng tôi xem xét tài liệu báo cáo về những khó khăn trong việc điều trị bệnh nhân như vậy.

Từ khóa

#thiếu tiểu cầu #huyết khối #hội chứng kháng phospholipid

Tài liệu tham khảo

Pasquali JL, Poindron V, Korganow AS, Martin T (2008) The antiphospholipid syndrome. Best Pract Res Clin Rheumatol 22(5):831–845 Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 376(9751):1498–1509 Sharma B, Kapoor S, Malaviya AN (2005) Refractory thrombocytopenia in antiphospholipid syndrome. J Assoc Physicians India 53:147–149 Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725 Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686 Turini RBF, Chechia TE, Fernandes TA, Bom APKP, Bandeira M (2012) Antiphospholipid syndrome and thrombocytopenia in childhood. Revista Paulista de Pediatri 30(3):443–449 Forastiero R (2012) Bleeding in the antiphospholipid syndrome. Hematology 17(Suppl 1):S153–S155 Lim W (2009) Antiphospholipid antibody syndrome. Hematology 1:233–239 Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, Masuhr F (2010) EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 17(10):1229–1235 Comarmond C, Cacoub P (2013) Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmun Rev 12(7):752–757 Comellas-Kirkerup L, Hernández-Molina G, Cabral AR (2010) Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study. Blood 116(16):3058–3063 George JN (2006) Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 4(8):1664–1672 Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z (2013) Autoimmunity and novel therapies in immune-mediated thrombocytopenia. Semin Hematol 50(Suppl 1):S100–S108 Kumar D, Roubey RA (2010) Use of rituximab in the antiphospholipid syndrome. Curr Rheumatol Rep 12(1):40–44 Parodis I, Axelsson M, Gunnarsson I (2013) Belimumab for systemic lupus erythematosus: a practice-based view. Lupus 22(4):372–380 Cooper N (2009) Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia. Hematol Oncol Clin North Am 23(6):1317–1327 Alper G, Berrak SG, Ekinci G, Canpolat C, Erzen C (1999) Sagittal sinus thrombosis associated with thrombocytopenia: a report of two patients. Pediatr Neurol 21(2):573–575 Al-Riyami AZ, Lee J, Connolly M, Shereck E (2011) Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura. Pediatr Blood Cancer 57(1):157–159 Kayyali HR, Abdelmoity AT, Morriss MC, Graf WD (2008) Cerebral venous thrombosis after immune thrombocytopenic purpura and Anti-D immune globulin therapy. J Child Neurol 23(3):325–330 Cervera R (2010) Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’. Lupus 19(4):412–418 Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ (2012) Catastrophic antiphospholipid syndrome (CAPS). Best Pract Res Clin Rheumatol 26(4):535–541 Galindo M, Khamashta MA, Hughes GR (1999) Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome. Rheumatology 38(9):848–853